Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Kaye

Showing results (361-370 of 411) with videos related to

Pageof 42
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Intergroup collaboration in ovarian cancer: a giant step forwardM J Piccart, G C Stuart, J Cassidy, et al.
Journal of the National Cancer Institute|May 26, 1999
Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working PartyL Collette, R J Sylvester, S P Stenning, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1992
Phase II trials of fosquidone (GR63178A) in carcinoma of the breast, head and neck, ovary and melanomaS B Kaye, J Wanders, M Clavel, et al.
Lancet (London, England)|August 8, 1992
Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancerS B Kaye, C R Lewis, J Paul, et al.
Progress in Clinical and Biological Research|January 1, 1990
Prognostic factors in metastatic germ cell tumorsG Stoter, G J Bosl, J P Droz, et al.
British Journal of Cancer|June 1, 1995
Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative GroupR de Wit, G Stoter, D T Sleijfer, et al.
Gynecologic Oncology|November 16, 2011
Outcomes of surgical management of bowel obstruction in relapsed epithelial ovarian cancer (EOC)D F Kolomainen, A Daponte, D P J Barton, et al.
British Journal of Cancer|November 12, 2015
Complications of hyperglycaemia with PI3K-AKT-mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trialsE Geuna, D Roda, S Rafii, et al.
British Journal of Cancer|August 1, 1994
Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group StudyC N Sternberg, W W ten Bokkel Huinink, J F Smyth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2012
A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancerS B Kaye, C J Poole, A Dańska-Bidzińska, et al.
Pageof 42

Showing results (361-370 of 411) with videos related to

Sort By:
Pageof 42
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Intergroup collaboration in ovarian cancer: a giant step forwardM J Piccart, G C Stuart, J Cassidy, et al.
Journal of the National Cancer Institute|May 26, 1999
Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working PartyL Collette, R J Sylvester, S P Stenning, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1992
Phase II trials of fosquidone (GR63178A) in carcinoma of the breast, head and neck, ovary and melanomaS B Kaye, J Wanders, M Clavel, et al.
Lancet (London, England)|August 8, 1992
Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancerS B Kaye, C R Lewis, J Paul, et al.
Progress in Clinical and Biological Research|January 1, 1990
Prognostic factors in metastatic germ cell tumorsG Stoter, G J Bosl, J P Droz, et al.
British Journal of Cancer|June 1, 1995
Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative GroupR de Wit, G Stoter, D T Sleijfer, et al.
Gynecologic Oncology|November 16, 2011
Outcomes of surgical management of bowel obstruction in relapsed epithelial ovarian cancer (EOC)D F Kolomainen, A Daponte, D P J Barton, et al.
British Journal of Cancer|November 12, 2015
Complications of hyperglycaemia with PI3K-AKT-mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trialsE Geuna, D Roda, S Rafii, et al.
British Journal of Cancer|August 1, 1994
Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group StudyC N Sternberg, W W ten Bokkel Huinink, J F Smyth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2012
A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancerS B Kaye, C J Poole, A Dańska-Bidzińska, et al.
Pageof 42